Bone vs Brain vs Liver vs Lung Metastasis Outcomes in Stage IV Metastatic Breast Cancer

  • Bone metastases were by far the most common (2953/4275 patients) and had the best survival outcomes.
  • ER/PR+ patients were more likely to have Bone metastases.
  • ER/PR/HER2- (TNBC) were more likely to have Brain and Lung metastasis
051015202530354045months0%20%40%60%80%100%survival
Estimated Survival at 25 Months:

With Bone Metastasis (n = 2,953):68%

With Lung Metastasis: (n = 668)54%

With Liver Metastasis: (n = 572)57%

With Brain Metastasis: (n = 82)27%

Scroll Down for More Data

Reference

Gong Y, Liu Y-R, Ji P, Hu X, Shao Z-M. Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study. Scientific Reports. 2017;7:45411. doi:10.1038/srep45411.